Notice ID: 1c0af703c4e84e248c965c2be5f2efe0Combined Synopsis/Solicitation
Q517--Media Fill & Fingertips Testing
Archived on July 8, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 4:00 PM UTC−07:00
- Posted
- June 20, 2021
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 262-NETWORK CONTRACT OFFICE 22 (36C262)
- Place of performance
- Department of Veterans Affairs VA Loma Linda Healthcare System Pharmacy Service 11201 Benton Street, Loma Linda, 92357
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C26221R0093
- Notice ID
- 1c0af703c4e84e248c965c2be5f2efe0
Description
Page | 2 of 2 Media Fill Testing (MFT) and Gloved Fingertip Testing (GFT) Services for the VA Loma Linda Healthcare System (VALLHS) Question and Responses from RFP: 36C26221R0093 Dated: June 23rd, 2021 Could you please tell me if the Combined Synopsis/Solicitation posted as solicitation number 36C26221R0093 will be a follow-on requirement to any work performed currently or in the past, or will this be a new requirement? Previous Purchase Order 36C26220P1328
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C26221R0093- Combined Synopsis
- 2×Combined SynopsisCurrentJun 9, 2021
Q517--Media Fill & Fingertips Testing
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. **Solicitation closing will be moved to WED 11/04/2026 @ 1500 EST. | 68% | Solicitation | 11/04/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. | 68% | Pre-Solicitation | 11/02/2026 |
Q515 - Notice of Intent to Sole-Source Requirement: Artera AI Prostate Exam Testing - Cleveland VAMC Notice of Intent to Sole-Source Requirement The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 541380, Size Standard is $19 Million. Product Service Code (PSC) is Q515. The sole-source contract will be awarded to: ARTERA, INC UEI: S8PHW2AWT2R7 Description of requirements: The VA Northeast Ohio Healthcare System (VANEOHS) requires access to specialized multi-modal artificial intelligence (MMAI) prostate risk stratification testing of prostate biopsies or surgical specimens to assess the likelihood and severity of prostate recurrence or progression. Multi-modal artificial intelligence (MMAI) is a precision medicine platform designed to optimize cancer treatment, primarily for prostate and breast cancer patients. This testing consists of the following to generate patient specific prostate cancer risk stratification: Data Integration: Artera AI analyzes H&E-stained pathology slides alongside patient clinical information, such as age, tumor stage, and lab results; Predictive Modeling: The AI algorithm predicts which patients are likely to benefit from specific therapies, such as short-term androgen deprivation therapy (ST-ADT) in prostate cancer; Outcome Estimation: It estimates long-term outcomes, including disease progression and metastasis risk, helping clinicians tailor treatment plans Artera AI Prostate is the first MMAI test recommended in the NCCN Clinical Practice Guidelines for prostate cancer. It identifies patients who may benefit most from hormone therapy and supports early-stage treatment decisions. Benefits of this testing are early intervention providing actionable insights to guide therapy selection and improve patient outcomes for our prostate cancer patients. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government. The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy: thomas.bellamy@va.gov and Samantha Jarrett: samantha.jarrett@va.gov by 3:00 p.m. EST November 10th, 2026. | 66% | Special Notice | 11/10/2026 |
This amendment is to correct the due date for quotes on the SF1449. changed from 12/02/2025 to 12/18/2025. VISN 8 is anticipating a Firm Fixed Indefinite Delivery Indefinite Quantity contract for VISN 8 EMERGENT PHARMACY FIRST FILL PRESCRIPTION SERVICES Base plus Four Option Years at the following VISN 8 VA Medical Centers and their outlying CBOCs, and CMBOCs. Locations are listed below. Bay Pines, Tampa, Orlando, North Florida/South Georgia, Miami, West Palm Beach, San Juan PR, and the Clinical Contact Center, Tampa FL. See PWS for futher information. Quotes are due NLT 10:00AM EST; December 30, 2025. | 54% | Solicitation | 12/30/2026 |
Thank you for your patience. Please see the attached Amendment 0007 and attachments for details. The purpose of this amendment is to: 1. Extend proposal closing date to 10:00 AM CST, December 18, 2025. 2. Section D, Attachments have been updated and revised. 3. Revise Section E, Addendum to FAR 52.212-1, Instructions to Offerors. 4. Update the Small Business Size standard associated with NAICS 561210. 5. Require updated Subcontractor Consent Letters. | 53% | Solicitation | 12/18/2025 |
Additional Details
Solicitation Number
36C26221R0093
Archive Date
Jul 8, 2021
Office Address
Gilbert, AZ, 85297